The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "Erbitux" ...
-
The cell game: Sam Waksal's fast money and false promises -- and the fate of ImClone's cancer drug
This book is a behind-the-scenes look at ImClone and the biotech company's CEO, Sam Waksal. ImClone's drug Erbitux promised a revolutionary way to treat cancer. Bristol-Myers Squibb signed an unprecedented $2 billion deal to market the drug. Waksal lived a life of luxury. But by late December 2001 the FDA rejected Erbitux because ImClone's science was "sloppy" and "incomplete." Waksal tried to cash in before his stock plummeted on the news. He forged signatures and traded his family's shares on inside information, an unfolding scandal that also ensnared Martha Stewart, a friend of Waksal. He is now in jail.
Tags: BOOK; ImClone; Erbitux; Waksal; cancer drug; insider trading; FDA; SEC; DOJ
-
ImClone Systems
An investigation by The Street.com revealed questions over ImClone Systems handling of its drug Erbitux, long before an early morning raid in June 2002 that ended with the company's CEO, Sam Waksal, handcuffed by police. In late 2001, The Street.com reported on a sweetheart loan that went to Waksal during negotiations with Bristol-Myers. It also reported that something was amiss with the Erbitux application two weeks before the Food and Drug Administration rejected the application. Throughout 2002, while others focused on the insider trading scandal involving Waksal and Martha Stewart, The Street.com remained focused on ImClone and "the trouble it was having getting Erbitux back on track.
Tags: ImClone Systems; Sam Waksal; insider trading; biotech; financial; Food and Drug Administration; Erbitux; online; CD
-
Who Knew?
New York looks at Martha Stewart, her private banker Peter Bacanovic and the ImClone scandal they both are embroiled in.
Tags: Martha Stewart; Peter Bacanovic; obstruction-of-justice charge; ImClone; Sam Waksal; Erbitux; FDA; investors; insider trading